Transient neuropathy after needle-free injection outside of recommended sites [2]

AIDS

Volumn 20, Issue 5, 2006, Pages 784-785

  Harris, Marianne ^a   Larsen, Gerene ^a   Valyi, Monica ^a   Walker, Ekaterina ^b   Montaner, Julio S G ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b Bioject Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE;

CASE REPORT; DEVICE; ELECTRIC SHOCK; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; INJECTION SITE REACTION; INJECTION SITE SWELLING; LETTER; NEUROPATHY; PAIN; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; SENSORY DYSFUNCTION;

HIV ENVELOPE PROTEIN GP41; HIV FUSION INHIBITORS; HIV INFECTIONS; HUMANS; INJECTIONS, JET; JOINTS; MALE; PEPTIDE FRAGMENTS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 33745081840     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000216385.52857.87     Document Type: Letter

References (2)

1. Harris M, Joy R, Larsen G, Valyi M, Walker E, Frick LW, et al. Enfuvirtide plasma levels and injection site reactions using a needle-free gas-powered injection system (Biojector). AIDS 2005; 20:719-723.
2. Professional Use Instruction Manual. Biojector 2000 Needle Free Injection Management System, 171-0120-01 Rev. D. Bioject Inc., Tualatin, OR, USA; January 14, 2005.